Description

Over the past few years the importance associated with determining a patient's complete response to a given compound has become increasingly apparent. Even if a compound is shown to be highly potent, effective and potentially an ideal and very promising drug, it will have no therapeutic potential if it has a poor pharmacokinetic profile. In an effort to determine and measure these profiles, companies are investing in technologies to provide important information regarding absorption, distribution, metabolism, excretion and toxicity properties (ADME/Tox) of compounds that are being synthesized in the discovery process.